These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19396461)

  • 1. What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis.
    Maurer M; Dondji B; von Stebut E
    Med Microbiol Immunol; 2009 Aug; 198(3):137-46. PubMed ID: 19396461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune response: ally or enemy in cutaneous leishmaniasis?
    Serrano-Coll H; Cardona-Castro N; Ramos AP; Llanos-Cuentas A
    Pathog Dis; 2021 Jun; 79(5):. PubMed ID: 34037758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin dendritic cells in murine cutaneous leishmaniasis.
    Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y
    Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.
    Feijó D; Tibúrcio R; Ampuero M; Brodskyn C; Tavares N
    J Immunol Res; 2016; 2016():3967436. PubMed ID: 26904694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous leishmaniasis: Distinct functions of dendritic cells and macrophages in the interaction of the host immune system with Leishmania major.
    von Stebut E; Tenzer S
    Int J Med Microbiol; 2018 Jan; 308(1):206-214. PubMed ID: 29129568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dectin-1 Positive Dendritic Cells Expand after Infection with
    Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
    Front Immunol; 2018; 9():263. PubMed ID: 29535708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity.
    Von Stebut E
    Eur J Dermatol; 2007; 17(2):115-22. PubMed ID: 17337393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conundrums in leishmaniasis.
    Saha B; Bhattacharjee S; Sarkar A; Bhor R; Pai K; Bodhale N
    Cytokine; 2021 Sep; 145():155304. PubMed ID: 33004260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines in the immunity and immunopathogenesis in leishmaniases.
    Saha B; Silvestre R
    Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice.
    Paul C; Wolff S; Zapf T; Raifer H; Feyerabend TB; Bollig N; Camara B; Trier C; Schleicher U; Rodewald HR; Lohoff M
    Eur J Immunol; 2016 Jan; 46(1):114-21. PubMed ID: 26449668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by
    Passelli K; Billion O; Tacchini-Cottier F
    Front Immunol; 2021; 12():649348. PubMed ID: 33732265
    [No Abstract]   [Full Text] [Related]  

  • 13. Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes.
    Baldwin T; Henri S; Curtis J; O'Keeffe M; Vremec D; Shortman K; Handman E
    Infect Immun; 2004 Apr; 72(4):1991-2001. PubMed ID: 15039319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous leishmaniasis in mast cell-deficient W/Wv mice.
    Katakura K; Saito S; Hamada A; Matsuda H; Watanabe N
    Infect Immun; 1993 May; 61(5):2242-4. PubMed ID: 8478118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host susceptibility factors to cutaneous leishmaniasis.
    Jones DE; Elloso MM; Scott P
    Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance.
    Kautz-Neu K; Schwonberg K; Fischer MR; Schermann AI; von Stebut E
    Med Microbiol Immunol; 2012 Nov; 201(4):581-92. PubMed ID: 22983754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Manifestations of Human and Murine Leishmaniasis.
    Scorza BM; Carvalho EM; Wilson ME
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection.
    Baldwin T; Sakthianandeswaren A; Curtis JM; Kumar B; Smyth GK; Foote SJ; Handman E
    Parasite Immunol; 2007 Oct; 29(10):501-13. PubMed ID: 17883453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity and Leishmania vaccination strategies.
    Birnbaum R; Craft N
    Dermatol Clin; 2011 Jan; 29(1):89-102. PubMed ID: 21095533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.